Exhibit 99.1

MAXIMUS Reports Second Quarter Results for Fiscal 2015

RESTON, Va.--(BUSINESS WIRE)--May 7, 2015--MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, today reported financial results for its second quarter ended March 31, 2015.

Highlights for the second quarter of fiscal 2015 include:

● Revenue growth of 10% to $481.8 million, driven by organic growth in the Health Services Segment

● GAAP diluted earnings per share of $0.58 and adjusted diluted earnings per share of $0.60

● Cash and cash equivalents that totaled $114.5 million at March 31, 2015

● A successful rebid and increased market share for the Company’s Australian workforce services operations under the new jobactive and Work for the Dole programs, which begins on July 1, 2015

● Signed year-to-date contract awards of $1.584 billion; new contracts pending of $1.048 billion, which includes the rebid win in Australia; and a robust sales pipeline of $2.6 billion at March 31, 2015

● An amendment to the Company’s credit facility, which now provides for a revolving line of credit up to $400 million and an uncommitted $200 million increase option

● Subsequent to quarter close, the completion of the acquisition of Acentia, a U.S. federal services company

For the second quarter of fiscal 2015, revenue increased 10% (12% on a constant currency basis) to $481.8 million, compared to $439.0 million reported for the same period last year. The increase in revenue was driven by organic growth from new work and the expansion of existing contracts, primarily in the Health Services Segment. Both revenue and earnings were better than expected in the second quarter of fiscal 2015 due to contract amendments that were larger than previously anticipated in the Health Services Segment.

Fiscal 2015 second quarter net income attributable to MAXIMUS totaled $38.8 million, or $0.58 per diluted share, and included approximately $0.02 per diluted share of acquisition-related expenses. Excluding these acquisition-related expenses, adjusted diluted earnings per share were $0.60 compared to $0.59 per diluted share for the same period last year.

“MAXIMUS has experienced many recent positive developments as we continue to grow the business and execute on our existing portfolio. On March 1, 2015, we successfully launched the new U.K. Health Assessment Advisory Service. Subsequent to quarter end, we signed a five-year, $940 million contract to continue to operate under the Australian jobactive program. This important rebid win includes an increase in market share from 12.5% to 15% and confirms our demonstrated success in achieving rigorous performance metrics and delivering the outcomes that matter to our government clients,” commented Richard A. Montoni, MAXIMUS Chief Executive Officer.

Montoni continued, “We are also keenly focused on strategic cash deployment and the creation of future growth platforms. In April, we completed the acquisition of Acentia and purchased a 70% interest in Remploy with the remaining 30% held by its employees. We believe these events will further support our growth objectives for our federal business in the U.S. and our human services business in the U.K. Our solid second quarter results reinforce our ability to meet our existing operational and financial goals, while laying the groundwork for ongoing, long-term growth.”

Health Services Segment

Health Services Segment revenue for the second quarter of fiscal 2015 increased 14% to $370.4 million, driven by organic growth from new work and the expansion of existing contracts. This compares to $323.6 million for the same period last year. The Segment’s second quarter 2015 results were ahead of the Company’s expectations due to certain contract amendments that were larger than previously anticipated.

Health Services Segment operating income for the second quarter totaled $51.1 million (13.8% operating margin) compared to operating income of $49.7 million (15.4% operating margin) reported last year. Operating margins were lower in the second quarter of fiscal 2015 compared to last year due to the expected lower volumes in the Company’s Medicare appeals business and certain new contracts in the start-up phase.

Human Services Segment

Human Services Segment revenue for the second quarter of fiscal 2015 totaled $111.4 million, compared to $115.4 million for the same period last year. The Segment continued to be impacted by unfavorable currency exchange rates, and on a constant currency basis, revenue would have increased 4%.

Human Services Segment operating income for the second quarter totaled $13.9 million (12.5% operating margin) compared to $17.3 million (15.0% operating margin) for the same period last year. The second quarter of fiscal 2014 benefitted from the finalization of a contract in Saudi Arabia and a couple of short-term consulting engagements in the United States that were highly accretive.

Sales and Pipeline

The Company posted record sales at March 31, 2015 with year-to-date signed contract awards totaling $1.584 billion. At March 31, 2015, new contracts pending (awarded but unsigned) totaled $1.048 billion, which includes the jobactive rebid contract in Australia.

Sales pipeline at March 31, 2015 was $2.6 billion (consisting of $528 million in proposals pending, $662 million in proposals in preparation, and $1.5 billion in opportunities tracking) and 18% higher than the sales pipeline of $2.2 billion reported at March 31, 2014. As expected, sales pipeline was lower on a sequential basis due to sales opportunities converting into new awards during the second quarter of fiscal 2015.

Balance Sheet and Cash Flows

Cash and cash equivalents at March 31, 2015 totaled $114.5 million, of which approximately 33% were held outside the United States. For the second quarter of fiscal 2015, cash provided by operating activities totaled $5.5 million, with negative free cash flow of $27.9 million. In the second quarter of fiscal 2015, the Company increased its capital investments for infrastructure modernization in support of its ongoing growth in the United States and the United Kingdom. At March 31, 2015, Days Sales Outstanding (DSOs) were 70 days and within the Company’s stated range of 65 to 80 days. As expected, both the increase in DSOs and deferred revenue were due, in part, to new contracts in the United Kingdom. The Company expects that DSOs will return to lower levels by the end of fiscal 2015.

On February 27, 2015, MAXIMUS paid a quarterly cash dividend of $0.045 per share. On April 7, 2015, the Company announced a $0.045 per share cash dividend, payable on May 29, 2015 to shareholders of record on May 15, 2015.

On March 9, 2015, MAXIMUS expanded its credit facility for a revolving line of credit up to $400 million and an uncommitted $200 million increase option. The facility is available for general corporate purposes and certain permitted acquisitions.

Subsequent to quarter close, the Company completed the acquisition of Acentia, which was an all-cash transaction and funded by cash on hand and $225 million borrowed under the expanded credit facility.

Outlook

MAXIMUS is increasing its forecasted fiscal year 2015 revenue range to $2.05 billion to $2.08 billion as a result of the acquisitions of Acentia and Remploy. The Company now expects fiscal year 2015 GAAP diluted earnings per share to range between $2.33 and $2.40, but with a bias towards the upper end of the range.

For the full fiscal year, the Company is forecasting that, on a combined basis, Acentia and Remploy will contribute between $0.07 and $0.09 of diluted earnings per share for the second half of fiscal 2015. As expected, this will be offset by the new jobactive program in Australia, with expected start-up losses in the fourth quarter of fiscal 2015, which the Company estimates will be $0.06 to $0.09 of diluted earnings per share.

The Company is also establishing preliminary guidance for fiscal 2016. MAXIMUS is forecasting revenue in the range of $2.4 billion to $2.5 billion for fiscal 2016 and estimates that GAAP diluted earnings per share will range from $2.85 to $3.05. The preliminary guidance considers the acquisitions of Acentia and Remploy, the rebid win in Australia and the expected growth from new and existing contracts that were in start-up in fiscal 2015. There are a number of variables that can impact this preliminary guidance, including changes in volumes, outcomes on performance-based contracts, fluctuations in currency and legislative changes.

Montoni concluded, “We are very pleased with our year-to-date performance, increased expectations for the full fiscal 2015 year and preliminary view on continued solid growth into fiscal year 2016. Our appreciation is again extended to the many hard-working employees around the globe, who now number approximately 16,000. We also want to extend a special welcome to our colleagues who are joining us from Remploy and Acentia.”

Website Presentation, Conference Call and Webcast Information

MAXIMUS will host a conference call this morning, May 7, 2015, at 9:00 a.m. (ET). The call is open to the public and can be accessed under the Investor Relations page of the Company’s website at http://investor.maximus.com or by calling:

877.407.8289 (Domestic)/+1.201.689.8341 (International)

For those unable to listen to the live call, a replay will be available through May 21, 2015. Callers can access the replay by calling:

877.660.6853 (Domestic)/+1.201.612.7415 (International)

Replay conference ID number: 13607890

About MAXIMUS

Since 1975, MAXIMUS has operated under its founding mission of Helping Government Serve the People®, enabling citizens around the globe to successfully engage with their governments at all levels and across a variety of health and human services programs. MAXIMUS delivers innovative business process management and technology solutions that contribute to improved outcomes for citizens and higher levels of productivity, accuracy, accountability and efficiency of government-sponsored programs. With approximately 16,000 employees worldwide, MAXIMUS is a proud partner to government agencies in the United States, Australia, Canada, New Zealand, Saudi Arabia and the United Kingdom. For more information, visit www.maximus.com.

Non-GAAP Measures

This release refers to non-GAAP financial measures, including adjusted diluted earnings per share, free cash flow, constant currency and days sales outstanding.

We have provided a reconciliation to adjusted diluted earnings per share. We believe that this measure is a useful basis for assessing the Company’s performance excluding the effect of acquisition expenses.

We have provided a reconciliation of free cash flow to cash provided by operating activities. We believe that free cash flow is a useful basis for investors to compare our performance across periods or against our competitors. Free cash flow shows the effects of the Company’s operations and routine capital expenditure and excludes the cash flow effects of acquisitions, share repurchases, dividend payments and other financing transactions.

To provide constant currency information, we calculate fiscal year 2015 revenue for all international businesses using the exchange rates used in the comparative period in fiscal year 2014. We believe constant currency provides a useful basis for assessing the performance of the business excluding the unpredictable effects of foreign exchange fluctuations.

Days sales outstanding, or DSO, is a measure of how efficiently we manage the billing and collection of our receivable balances. We calculate DSO by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operating activities, revenue growth or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

Statements that are not historical facts, including statements about the Company’s confidence and strategies and the Company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand or acceptance of the Company’s products are forward-looking statements that involve risks and uncertainties. These uncertainties could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements and include reliance on government clients; risks associated with government contracting; risks involved in managing government projects; legislative changes and political developments; opposition from government unions; challenges resulting from growth; adverse publicity; and legal, economic, and other risks detailed in Exhibit 99.1 to the Company’s most recent Annual Report filed with the Securities and Exchange Commission, found on www.maximus.com.

MAXIMUS, Inc. CONSOLIDATED STATEMENTS OF OPERATIONS (Amounts in thousands, except per share data) (Unaudited)
	Three Months						Six Months
	Ended March 31,						Ended March 31,
	2015			2014			2015			2014
Revenue	$	481,794		$	439,015		$	948,837		$	845,607
Cost of revenue		357,449			318,343			705,225			619,019
Gross profit		124,345			120,672			243,612			226,588
Selling, general and administrative expenses		59,392			53,624			111,353			104,889
Amortization of intangible assets		1,432			1,468			2,907			2,823
Acquisition-related expenses		1,514			—			2,114			—
Legal and settlement expenses		—			600			—			600
Operating income		62,007			64,980			127,238			118,276
Interest and other income, net		219			476			1,120			808
Income before income taxes		62,226			65,456			128,358			119,084
Provision for income taxes		23,198			23,995			46,980			44,268
Net income		39,028			41,461			81,378			74,816
(Income)/loss attributable to non-controlling interests		(220	)		(254	)		(709	)		250
Net income attributable to MAXIMUS	$	38,808		$	41,207		$	80,669		$	75,066
Basic earnings per share attributable to MAXIMUS	$	0.59		$	0.61		$	1.22		$	1.10
Diluted earnings per share attributable to MAXIMUS	$	0.58		$	0.59		$	1.20		$	1.08
Dividends paid per share	$	0.045		$	0.045		$	0.09		$	0.09
Weighted average shares outstanding:
Basic		65,862			67,884			65,899			68,143
Diluted		66,987			69,307			66,947			69,538

MAXIMUS, Inc. CONSOLIDATED BALANCE SHEETS (Amounts in thousands)
	March 31, 2015		September 30, 2014
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	114,535	$	158,112
Accounts receivable — billed and billable, net of reserves of $4,004 and $3,138		339,527		263,011
Accounts receivable — unbilled		28,845		26,556
Deferred income taxes		32,572		28,108
Prepaid expenses and other current assets		54,530		56,673
Total current assets		570,009		532,460
Property and equipment, net		103,234		80,246
Capitalized software, net		35,311		39,734
Goodwill		162,214		170,626
Intangible assets, net		34,031		39,239
Deferred contract costs, net		19,005		12,046
Deferred compensation plan assets		21,003		17,126
Other assets, net		10,154		9,519
Total assets	$	954,961	$	900,996
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	126,122	$	103,181
Accrued compensation and benefits		67,765		94,137
Deferred revenue		55,096		55,878
Income taxes payable		16,887		4,693
Other liabilities		6,951		7,432
Total current liabilities		272,821		265,321
Deferred revenue, less current portion		50,682		32,257
Deferred income taxes		15,930		21,383
Deferred compensation plan liabilities, less current portion		20,973		18,768
Other liabilities		6,326		7,082
Total liabilities		366,732		344,811
Shareholders’ equity:
Common stock, no par value		438,373		429,857
Accumulated other comprehensive income/(loss)		(20,803		230
Retained earnings		169,802		125,875
Total MAXIMUS shareholders’ equity		587,372		555,962
Non-controlling interests		857		223
Total equity		588,229		556,185
Total liabilities and equity	$	954,961	$	900,996

MAXIMUS, Inc. CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited)
	Three Months Ended March 31,						Six Months Ended March 31,
	2015			2014			2015			2014
Cash flows from operating activities:
Net income	$	39,028		$	41,461		$	81,378		$	74,816
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, equipment and capitalized software		12,739			10,267			23,706			20,936
Amortization of intangible assets		1,432			1,468			2,907			2,823
Deferred income taxes		(9,209	)		(9,046	)		(10,134	)		(1,387	)
Non-cash equity based compensation		4,470			4,480			8,436			8,561
Change in assets and liabilities:
Accounts receivable — billed		(76,641	)		(32,250	)		(80,883	)		(37,516	)
Accounts receivable — unbilled		2,003			1,245			(2,311	)		(50	)
Prepaid expenses and other current assets		(5,822	)		2,338			(6,043	)		2,539
Deferred contract costs		(3,651			625			(7,105	)		1,979
Accounts payable and accrued liabilities		13,833			4,193			27,274			3,627
Accrued compensation and benefits		11,638			10,504			(12,263	)		(7,450	)
Deferred revenue		18,248			(5,168	)		21,858			(6,211	)
Income taxes		747			4,081			19,583			10,153
Other assets and liabilities		(3,343	)		316			(4,337	)		3,640
Cash provided by operating activities		5,472			34,514			62,066			76,460
Cash flows from investing activities:
Purchases of property and equipment		(31,472	)		(5,076	)		(44,226	)		(9,516	)
Capitalized software costs		(1,891	)		(3,733	)		(3,247	)		(7,317	)
Acquisition of business		—			(2,670	)		—			(2,670	)
Proceeds from note receivable		122			39			282			154
Cash used in investing activities		(33,241	)		(11,440	)		(47,191	)		(19,349	)
Cash flows from financing activities:
Cash dividends paid		(2,966	)		(3,053	)		(5,928	)		(6,138	)
Repurchases of common stock		—			(13,166	)		(32,616	)		(34,696	)
Tax withholding related to RSU vesting and option exercises		(116			(101	)		(12,453	)		(12,905	)
Stock option exercises		—			191			—			518
Expansion of credit facility		(1,444			—			(1,444			—
Borrowings under credit facility		—			15,000			—			15,000
Repayment of credit facility and other long-term debt		(35			(15,040	)		(74			(15,082	)
Tax benefit due to option exercises and RSU vesting		—			2,925			—			2,925
Cash used in financing activities		(4,561	)		(13,244	)		(52,515	)		(50,378	)
Effect of exchange rate changes on cash and cash equivalents		(2,331	)		909			(5,937	)		(1,027	)
Net increase/(decrease) in cash and cash equivalents		(34,661	)		10,739			(43,577	)		5,706
Cash and cash equivalents, beginning of period		149,196			120,584			158,112			125,617
Cash and cash equivalents, end of period	$	114,535		$	131,323		$	114,535		$	131,323

MAXIMUS, Inc. SEGMENT INFORMATION (Amounts in thousands) (Unaudited)
	Three Months Ended March 31,											Six Months Ended March 31,
	2015			%(1)			2014			%(1)			2015			%(1)			2014			%(1)
Revenue:
Health Services	$	370,383		100	%	$	323,598			100	%	$	721,682			100	%	$	622,182			100	%
Human Services		111,411		100	%		115,417			100	%		227,155			100	%		223,425			100	%
Total		481,794		100	%		439,015			100	%		948,837			100	%		845,607			100	%
Gross Profit:
Health Services		91,887		24.8	%		84,868			26.2	%		177,302			24.6	%		161,374			25.9	%
Human Services		32,458		29.1	%		35,804			31.0	%		66,310			29.2	%		65,214			29.2	%
Total		124,345		25.8	%		120,672			27.5	%		243,612			25.7	%		226,588			26.8	%
Selling, general, and administrative expense:
Health Services		40,774		11.0	%		35,133			10.9	%		75,031			10.4	%		69,308			11.1	%
Human Services		18,523		16.6	%		18,528			16.1	%		36,222			15.9	%		35,602			15.9	%
Other		95		NM			(37	)	NM				100		NM				(21	)	NM
Total		59,392		12.3	%		53,624			12.2	%		111,353			11.7	%		104,889			12.4	%
Operating income:
Health Services		51,113		13.8	%		49,735			15.4	%		102,271			14.2	%		92,066			14.8	%
Human Services		13,935		12.5	%		17,276			15.0	%		30,088			13.2	%		29,612			13.3	%
Amortization of intangible assets		(1,432	)	NM			(1,468	)	NM				(2,907	)	NM				(2,823	)	NM
Acquisition-related expenses(2)		(1,514	)	NM			—		NM				(2,114	)	NM				—		NM
Legal and settlement expenses(3)		—		NM			(600	)	NM				—		NM				(600	)	NM
Other		(95	)	NM			37		NM				(100	)	NM				21		NM
Total	$	62,007		12.9	%	$	64,980			14.8	%	$	127,238			13.4	%	$	118,276			14.0	%

(1)	Percentage of respective segment revenue. Changes not considered meaningful are marked “NM.”
(2)	Acquisition-related expenses are costs directly incurred from the purchases of Acentia and Remploy.
(3)	Legal and settlement expenses consist of costs related to significant legal settlements and non-routine legal matters, including future probable legal costs expected to be incurred in connection with those matters. Legal expenses incurred in the ordinary course of business are included in their respective operating segments.

MAXIMUS, Inc. ADJUSTED DILUTED EARNINGS PER SHARE (Unaudited)
	Quarter Ended							Six Months Ended
	Dec. 31, 2014			Mar. 31, 2015				Mar. 31 2015
Diluted EPS-GAAP basis		$	0.63		$	0.58			$	1.22
Acquisition-related expenses			–			0.02				0.02
Adjusted Diluted EPS		$	0.63		$	0.60			$	1.24
	Quarter Ended							Six Months Ended
	Dec. 31, 2013			Mar. 31, 2014				Mar. 31 2014
Diluted EPS-GAAP basis		$	0.49		$	0.59			$	1.08
Adjustments:
Legal and settlement expenses			–			0.01				–
Tax Adjustment			–			(0.01	)			(0.01	)
Subtotal pro forma adjustments			–			–				–
Adjusted Diluted EPS		$	0.49		$	0.59			$	1.07

MAXIMUS, Inc. FREE CASH FLOW (Amounts in thousands) (Unaudited)
	Three Months Ended March 31,								Six Months Ended March 31,
	2015				2014				2015				2014
Cash provided by operating activities		$	5,472			$	34,514			$	62,066			$	76,460
Purchases of property and equipment			(31,472	)			(5,076	)			(44,226	)			(9,516	)
Capitalized software costs			(1,891	)			(3,733	)			(3,247	)			(7,317	)
Free cash flow		$	(27,891	)		$	25,705			$	14,593			$	59,627

CONTACT:

MAXIMUS, Inc.

Lisa Miles, 703-251-8637

lisamiles@maximus.com